I-Chitosan ivame ukutholakala njengengxenye yokuthenga ezitolo zempilo nama-pharmacy. Lo mkhiqizo utholakala ku-chitin, okuyingxenye enkulu yegobolondo, ngaphandle kwegobolondo ukuthi ama-crustaceans nezinambuzane zinayo. Iphinde iyingxenye yodonga lweseli lefungi.
Ucwaningo luye lwabangela imiphumela ezuzisayo yokuthatha i-chitosan, kuhlanganise ukulahlekelwa isisindo, ukuphulukiswa kwesilonda, ukunciphisa ama-plaque wamazinyo, nokwelapha ubuthongo.
Phakathi nezifundo ezithile ezihlola izinzuzo zezempilo ze-chitosan, kwaphinde kwavezwa ukuthi ukwesekwa kungase kunciphise amazinga e-cholesterol ne-triglyceride.
Ingabe I-Chitosan Isebenza Ngempela?
Ucwaningo lokuhlola imiphumela ye-lipid-downing ye-chitosan ibonakala iphikisana. Ucwaningo oluthile lwembula ukuthi i-chitosan inamandla okuthinta izici ezithile zephrofayili yakho ye-lipid, kanti ezinye izicwaningo zibonisa ukuthi i-chitosan ingase ingabi nomthelela omkhulu ezindlini ezithile ze-lipids. Ucwaningo lokuhlola ukusebenza kwe-chitosan kuma-cholesterol namazinga e-triglyceride kuye kwenziwa ezilwaneni, abantu abakhulu kakhulu, labo abane-type II yesifo sikashukela, abantu abane-cholesterol ephezulu, nabantu abadala abanempilo.
Izifundo eziningi ezibandakanya abantu abanempilo abangenazo izinguquko endleleni yabo yokuphila azizange zihloniphe izinga eliphezulu le-lipid, ngaphandle kokucwaninga okuye kwaholela ekunciphiseni amaphesenti angu-6 emazingeni ephelele we-cholesterol kanye nokwanda kwamaphesenti angu-7 kumazinga we-HDL ye-cholesterol.
Kodwa-ke, ezinye izifundo ezibandakanya abahlanganyeli nge- type 2 yesifo sikashukela , amazinga aphezulu e-cholesterol kanye / noma ukukhuluphala ngokweqile ngokulandela ukudla okunempilo, okuphansi kwekhalori (cishe ama-khilomitha angu-1200 ngosuku) kuphawula ukuthi amazinga e-cholesterol aphelele ancipha ngamaphesenti angaba ngu-8 namazinga e- LDL ama- cholesterol yehla ngamaphesenti angu-5.
Umphumela we-chitosan kuma-triglyceride nama-HDL amazinga we-cholesterol kulezi zifundo zahlanganiswa. Kwezinye izimo, amazinga we- triglyceride nama-HDL awazange athathwe, kanti ezinye izifundo zithinta umphumela omncane, omuhle ku-triglycerides noma i-HDL cholesterol. Kunzima ukucacisa ukuthi noma yini i-chitosan, ukudla okunempilo okulandelwa abahlanganyeli, noma bobabili babe nomthelela omuhle kumazinga e-lipid kulezi zifundo.
Amanani we-chitosan anikezwe kulezi zifundo nawo ahlukene kakhulu, kusukela ku-125 kuya ku-6,000 mg nsuku zonke, ngokuvamile ahlinzekwa ngokudla okulinganiselwe kuwo wonke usuku. Lezi zifundo zahlala kuphi phakathi kweviki elilodwa nezinyanga ezine. Kucatshangwa ukuthi i-chitosan ingase isebenze ngokubopha i-cholesterol ne-lipids emathangeni omzimba futhi ivimbele ukuba bangene emgodleni wegazi.
Ukuthatha i-Chitosan ukuze unciphise amazinga wakho we-cholesterol
Ucwaningo lwamanje lubonisa ukuthi i-chitosan inganciphisa ngokulinganisa i-LDL namazinga ephelele we-cholesterol. Kodwa-ke, ngoba kudingeke ucwaningo olwengeziwe ukuze uqhubeke nokuhlola umphumela we-chitosan kuphrofayela yakho ye-lipid, kufanele ufune ezinye izinyathelo zokunciphisa amazinga wakho we-cholesterol nama-triglyceride ngaphambi kokuzama ukwehlisa i-lipids yakho ne-chitosan.
I-Chitosan ayizange ibonakale ibe nemiphumela emibi kakhulu kulezi zifundo, kodwa ingabangela ukuphoqeka, ukuqothulwa, nokucabangela.
I-Chitosan ayizange isetshenziswe isikhathi eside, futhi kunezifundo ezithile zezilwane ezibonisa ukuthi i-chitosan ingasebenzisana namanye amavithamini amaningi anamafutha (njengevithamini D, A, no-E) uma kuthathwa isikhathi eside. Njengawo wonke umkhiqizo wemvelo, qiniseka ukuthi ukhuluma nomhlinzeki wakho wezempilo mayelana nokuthatha i-chitosan ngaphambi kokuzama ukuze uqinisekise ukuthi lesi sengezo asihlanganyeli nanoma yiziphi izimo zezempilo noma imithi ongayithatha.
Imithombo:
Izihlangu zeKM, uSmock N, McQueen CE, et al. I-Chitosan yokulahlekelwa isisindo nokuphathwa kwe-cholesterol. Am J Health Sys Pharm 2003; 60: 1310-1313.
Xu G, Huang X, Qiu L et al. Ucwaningo lwe-chitosan lwama-mechanism kwi-lipid metabolism kuma-rats angama-hyperlipidemic. Asia Pac J Clin Nutrition 2007; 16: 313-317
Tapola NS, Lyyra ML, Kolehmainen RM, et al. Izici zokuphepha kanye ne-cholesterol-ukwehlisa ukusebenza kwamaphilisi e-chitosan. J Am Coll Nutrition 2008; 27: 22-30.538-42.
Rizzo M, Giglio RV, Nikolic D et al. Imiphumela ye-chitosan kuma-plasma lipids nama-lipoprotein: isifundo se-pilot esingaba inyanga engu-4. I-Angiology 2014; 65.
Standard Standard. (2014). I-Chitosan [i-Monograph]. Ibuyiswe kusuka ku-http://naturalstandard.com/databases/hw/all/patient-chitosan.asp